Content sections
Contact information:

Anna Ratcliff in Oxford, UK | anna.ratcliff@oxfam.org | +44 7796 993288
Annie Thériault in Montreal, Canada | annie.theriault@oxfam.org | +51 936 307 990

For updates, please follow @Oxfam

Please support Oxfam's Coronavirus Response Appeal

Notes to editors:

A background briefing paper is available on request.

The Gates Foundation estimated the cost of producing and distributing a vaccine and have confirmed that this cost relates to the production and distribution in low and lower middle income countries only.

2019 profits for the top ten pharmaceutical companies.

Gilead monopoly decision, future Gilead cost of remdesivir and remdesivir potential cost per patient.

Oxfam believes that vaccines should ideally be produced and supplied for no more than $2 per dose. This is a reasonable challenge to set given that new complex vaccines for big killers like pneumonia are already available for this price.